Interleukin-27 Signaling Promotes Immunity against Endogenously Arising Murine Tumors

• Karlo D. T. Natividad,

  Affiliation Immunological Diseases Division, Garvan Institute of Medical Research, Sydney, New South Wales, Australia

  ⨯
• Simon R. Junankar,

  Affiliation Cancer Division, Garvan Institute of Medical Research, Sydney, New South Wales, Australia

  ⨯
• Norhanani Mohd Redzwan,

  Affiliation Immunological Diseases Division, Garvan Institute of Medical Research, Sydney, New South Wales, Australia

  ⨯
• Radhika Nair,

  Affiliation Cancer Division, Garvan Institute of Medical Research, Sydney, New South Wales, Australia

  ⨯
• Rushika C. Wirasinha,

  Affiliation Immunological Diseases Division, Garvan Institute of Medical Research, Sydney, New South Wales, Australia

  ⨯
• Cecile King,

  Affiliations Immunological Diseases Division, Garvan Institute of Medical Research, Sydney, New South Wales, Australia, St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia

  ⨯
• Robert Brink,

  Affiliations Immunological Diseases Division, Garvan Institute of Medical Research, Sydney, New South Wales, Australia, St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia

  ⨯
• Alexander Swarbrick,

  Affiliations Cancer Division, Garvan Institute of Medical Research, Sydney, New South Wales, Australia, St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia

  ⨯
• Marcel Batten

  * E-mail: m.batten@garvan.org.au

  Affiliations Immunological Diseases Division, Garvan Institute of Medical Research, Sydney, New South Wales, Australia, St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia

  ⨯